Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Thumbnail

Older patients optimistic about technology's ability to improve medication adherence

Patients over 65 years old welcomed the idea of using technology to improve cardiovascular medication adherence, according to a study published May 6 in the Journal of International Medical Research.

3 things to know about ‘healthcare voters’ in 2018 elections

Four states held primary elections on May 8, kicking off a busy election season that will see most Tuesdays from now until mid-September having one or more states’ voters casting ballots. Judging by the latest poll from the Kaiser Family Foundation, healthcare will be a major issue for many in the coming months.

Thumbnail

Trump’s pharma plan: Raise prices overseas to lower them in US

President Donald Trump is set to deliver a speech on pharmaceutical prices on May 11—but rather than matching his campaign rhetoric saying drug industry is “getting away with murder,” he’s expected to be cheered by pharma companies for calling for foreign countries to pay more for drugs, rather than bring down prices in the U.S.

Thumbnail

Hospitals without competition have higher prices

When hospitals enjoy a monopoly in their market, their prices for privately insured patients are 12.5 percent higher on average, according to a study encompassing 88 million people covered by Aetna, Humana and UnitedHealthcare. The differences disappeared when consolidating facilities were located more than 25 miles apart.

Addressing EHR regulatory requirements as the cause of burnout

Regulatory requirements could be a main reason for physician dissatisfaction and increased burnout with electronic health records (EHRs), according to an Ideas and Opinions piece published May 8 in the Annals of Internal Medicine.

Thumbnail

Japan pharma giant Takeda to buy Shire for $62B

Japan’s Takeda Pharmaceuticals has announced it will acquire Shire, an Ireland-based drug company, for $62 billion, making Takeda one of the 10 largest pharma firms in the world.

Thumbnail

External candidates may make more effective hospital CEOs

Looking at the transition in leadership at 490 hospitals, a study found 82 facilities chose a new chief executive from among their existing C-suite leaders, while the vast majority—408 hospitals—went with an outside hire.

Thumbnail

ACA stabilization bill is dead, says Republican sponsor, as insurers propose major premium hikes

Sen. Lamar Alexander, R-Tennessee, has said he’s abandoning efforts to push a bipartisan bill meant to stabilize the Affordable Care Act (ACA) exchanges, putting the blame on Democrats’ resistance to making changes to the law. With no congressional action likely this far into an election year, exchange insurers are requesting some eye-popping hikes for 2019 premiums.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup